Company intelligence / Profile preview

SmartAlpha

Ownership: Private
Development stage: Other

Overview

SmartAlpha has developed and commercialized an artificial intelligence platform that transforms grayscale ultrasound images into intuitive, anatomy-aware visuals to assist healthcare professionals in performing ultrasound scans across diverse settings. Their flagship product, Nerveblox, provides AI guidance for pain medicine and regional anesthesia procedures.

Therapeutic areas: Other
Modalities: Device (medical imaging AI software)
Industry: Medical Imaging

Beyond the preview

Go deeper on SmartAlpha.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SmartAlpha.

Explore the full profile